Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/32278
Title: Seladin-1/DHCR24 expression in normal ovary, ovarian epithelial and granulosa tumours.
Authors: Alexiadis M.;Jobling T. ;McNeilage J.;Fuller P.J.
Institution: (Fuller, Alexiadis, Jobling, McNeilage) Prince Henry's Institute of Medical Research, Department of Gynaecology Oncology, Monash Medical Centre, Clayton, Vic. 3168, Australia (Fuller) Prince Henry's Institute of Medical Research, PO Box 5152, Clayton, Vic. 3168, Australia
Issue Date: 17-Oct-2012
Copyright year: 2005
Publisher: Blackwell Publishing Ltd (9600 Garsington Road, Oxford OX4 2XG, United Kingdom)
Place of publication: United Kingdom
Publication information: Clinical Endocrinology. 63 (1) (pp 111-115), 2005. Date of Publication: July 2005.
Abstract: Objective: The human DIMINUTO/DWARF1 homolog seladin-1/DHCR24 has been recently reported to be up-regulated in adrenocortical adenomas. Seladin-1 expression has been reported in the normal ovary. Granulosa cell tumours of the ovary (GCT) as with adrenocortical adenomas arise from a steroidogenic tissue, respond to pituitary hormone stimulation and synthesize steroid hormones. Design(s): To test the hypothesis that seladin-1 may also have a role in the pathogenesis of GCT, we determined the expression of seladin-1 in a cohort of GCT and in mucinous and serous cystadenocarcinomas and in normal ovary. Measurements: Expression was determined by RT-PCR using gene specific primers and probes combined with Southern blot analysis of the PCR products. Result(s): Seladin-1 expression was identified in the normal ovary, mucinous cystadenocarcinomas and serous cystadenocarcinomas of the ovary whereas no expression was observed in the GCT. Conclusion(s): Based on our results, seladin-1 is not expressed in the granulosa cells or at least not in those that give rise to GCT. © 2005 Blackwell Publishing Ltd.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/j.1365-2265.2005.02308.x
PubMed URL: 15963070 [http://www.ncbi.nlm.nih.gov/pubmed/?term=15963070]
ISSN: 0300-0664
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/32278
Type: Article
Subjects: clinical article
controlled study
cystadenocarcinoma
female
gene control
*gene expression
gene function
*granulosa cell tumor/et [Etiology]
human
human tissue
mucinous carcinoma
*ovary tumor/et [Etiology]
pathogenesis
priority journal
*protein localization
reverse transcription polymerase chain reaction
Southern blotting
steroidogenesis
upregulation
*gene product/ec [Endogenous Compound]
unclassified drug
*3beta hydroxysteroid delta24 reductase/ec [Endogenous Compound]
*seladin 1/ec [Endogenous Compound]
adrenal cortex tumor
adult
aged
article
human tissue
mucinous carcinoma
*ovary tumor / *etiology
pathogenesis
priority journal
*protein localization
reverse transcription polymerase chain reaction
Southern blotting
steroidogenesis
gene function
upregulation
*gene expression
gene control
female
cystadenocarcinoma
controlled study
clinical article
article
aged
adult
adrenal cortex tumor
*granulosa cell tumor / *etiology
human
Appears in Collections:Articles

Show full item record

Page view(s)

4
checked on Sep 2, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.